## Diagnosis: Meniere Disease ### Clinical Presentation **Key Point:** Meniere disease is characterized by the classic tetrad of episodic vertigo, fluctuating sensorineural hearing loss, tinnitus, and aural fullness — all present in this patient. ### Diagnostic Features | Feature | Finding in This Case | Significance | |---------|----------------------|---------------| | **Vertigo** | Episodic, 2–3 hours | Typical duration (20 min–several hours) | | **Hearing Loss** | Low-frequency SNHL (250–1000 Hz) | Pathognomonic for Meniere; high frequencies spared early | | **Tinnitus** | Present | Fluctuates with disease activity | | **Aural Fullness** | Yes | Due to endolymphatic hydrops | | **Caloric Response** | Reduced on left | Indicates vestibular involvement | | **MRI** | Normal | Rules out retrocochlear pathology (e.g., acoustic neuroma) | ### Pathophysiology **High-Yield:** Meniere disease results from **endolymphatic hydrops** — abnormal accumulation of endolymph in the cochlea and vestibule. This causes: 1. Rupture of Reissner's membrane → mixing of endolymph and perilymph 2. Acute potassium influx into vestibular and cochlear hair cells 3. Depolarization → vertigo, hearing loss, tinnitus ### Diagnostic Criteria (Definite Meniere Disease) **Mnemonic: AAAA** - **A**ural fullness (aural symptoms) - **A**udiometric evidence (low-frequency SNHL) - **A**ttacks of vertigo (2 or more, 20 min–12 hours) - **A**ll other causes excluded ### Why MRI is Important **Clinical Pearl:** Normal MRI excludes retrocochlear lesions (acoustic neuroma, MS). Gadolinium-enhanced MRI may show endolymphatic sac enlargement in Meniere disease, but diagnosis is primarily clinical. ### Management Overview ```mermaid flowchart TD A[Meniere Disease Diagnosed]:::outcome --> B{Frequency & Severity?}:::decision B -->|Mild/Infrequent| C[Conservative: Salt restriction, diuretics]:::action B -->|Moderate| D[Intratympanic corticosteroids or gentamicin]:::action B -->|Severe/Refractory| E[Surgical: Endolymphatic sac decompression or labyrinthectomy]:::action C --> F[Reassess in 3 months]:::action D --> F E --> G[Symptom control achieved]:::outcome ``` ### Acute Attack Management - Bed rest, antiemetics (prochlorperazine, dimenhydrinate) - Vestibular suppressants (betahistine, meclizine) - Avoid sudden head movements [cite:Hazarika ENT Ch 8] 
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.